Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's diseaseQi Li, Haopeng Sun, Hongyu Yang et al.|European Journal of Medicinal Chemistry|2017Cited by 307
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's diseaseQi Li, Haopeng Sun, Yao Chen et al.|European Journal of Medicinal Chemistry|2018Cited by 200
Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and NeuroprotectionQi Li, Haopeng Sun, Ying Chen et al.|Journal of Medicinal Chemistry|2021Cited by 72
Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010–2020)Yunheng Li, Haopeng Sun, Shenghu Sang et al.|European Journal of Medicinal Chemistry|2021Cited by 69
ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma ProgressionYao Chen, Yongqing Liu|Scientific Reports|2017Cited by 58